233 related articles for article (PubMed ID: 17222937)
1. Expression of short hairpin RNAs against the coxsackievirus B3 exerts potential antiviral effects in Cos-7 cells and in mice.
Kim JY; Chung SK; Hwang HY; Kim H; Kim JH; Nam JH; Park SI
Virus Res; 2007 Apr; 125(1):9-13. PubMed ID: 17222937
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of coxsackievirus B3 replication by small interfering RNAs requires perfect sequence match in the central region of the viral positive strand.
Yuan J; Cheung PK; Zhang HM; Chau D; Yang D
J Virol; 2005 Feb; 79(4):2151-9. PubMed ID: 15681418
[TBL] [Abstract][Full Text] [Related]
3. Developing an effective RNA interference strategy against a plus-strand RNA virus: silencing of coxsackievirus B3 and its cognate coxsackievirus-adenovirus receptor.
Werk D; Schubert S; Lindig V; Grunert HP; Zeichhardt H; Erdmann VA; Kurreck J
Biol Chem; 2005 Sep; 386(9):857-63. PubMed ID: 16164410
[TBL] [Abstract][Full Text] [Related]
4. [Short interfering RNA-mediated inhibition of coxsakievirus B3 infection in vitro].
Han JS; Xiao ZH; Yao HL; Ren HY; Liu ZW
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2007 Jun; 21(2):150-2. PubMed ID: 17653320
[TBL] [Abstract][Full Text] [Related]
5. Targeting 2A protease by RNA interference attenuates coxsackieviral cytopathogenicity and promotes survival in highly susceptible mice.
Merl S; Michaelis C; Jaschke B; Vorpahl M; Seidl S; Wessely R
Circulation; 2005 Apr; 111(13):1583-92. PubMed ID: 15795330
[TBL] [Abstract][Full Text] [Related]
6. Maintaining inhibition: siRNA double expression vectors against coxsackieviral RNAs.
Schubert S; Grunert HP; Zeichhardt H; Werk D; Erdmann VA; Kurreck J
J Mol Biol; 2005 Feb; 346(2):457-65. PubMed ID: 15670596
[TBL] [Abstract][Full Text] [Related]
7. Interference of porcine reproductive and respiratory syndrome virus replication on MARC-145 cells using DNA-based short interfering RNAs.
He YX; Hua RH; Zhou YJ; Qiu HJ; Tong GZ
Antiviral Res; 2007 May; 74(2):83-91. PubMed ID: 16730075
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of West Nile virus replication in cells stably transfected with vector-based shRNA expression system.
Ong SP; Chu JJ; Ng ML
Virus Res; 2008 Aug; 135(2):292-7. PubMed ID: 18514349
[TBL] [Abstract][Full Text] [Related]
9. [Inhibitory effect of CVB3-VP1 siRNA on CVB3 replication].
Chen JB; Xu CF; Yu Y; Li L; Li SJ; Chen RZ; Yang YZ
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2006 May; 22(3):306-9. PubMed ID: 16643786
[TBL] [Abstract][Full Text] [Related]
10. [Intracellular clearance of Coxsakievirus B3 infection by short interfering RNA and its mechanism study].
Xiao ZH; Han JS; Yao HL; Liu ZW
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2008 Aug; 22(4):260-2. PubMed ID: 19105337
[TBL] [Abstract][Full Text] [Related]
11. Adenovirus-mediated shRNA interference against porcine circovirus type 2 replication both in vitro and in vivo.
Feng Z; Jiang P; Wang X; Li Y; Jiang W
Antiviral Res; 2008 Mar; 77(3):186-94. PubMed ID: 18199493
[TBL] [Abstract][Full Text] [Related]
12. Strand-specific silencing of a picornavirus by RNA interference: evidence for the superiority of plus-strand specific siRNAs.
Schubert S; Rothe D; Werk D; Grunert HP; Zeichhardt H; Erdmann VA; Kurreck J
Antiviral Res; 2007 Mar; 73(3):197-205. PubMed ID: 17112603
[TBL] [Abstract][Full Text] [Related]
13. Stringent testing identifies highly potent and escape-proof anti-HIV short hairpin RNAs.
von Eije KJ; ter Brake O; Berkhout B
J Gene Med; 2009 Jun; 11(6):459-67. PubMed ID: 19384894
[TBL] [Abstract][Full Text] [Related]
14. Design of LNA-modified siRNAs against the highly structured 5' UTR of coxsackievirus B3.
Dutkiewicz M; Grunert HP; Zeichhardt H; Lena SW; Wengel J; Kurreck J
FEBS Lett; 2008 Sep; 582(20):3061-6. PubMed ID: 18691577
[TBL] [Abstract][Full Text] [Related]
15. [Inhibitory effect of Chinese herbal medicine Xin-Kang oral liquid on replication of CVB3 RNA in Coxsackievirus B3 infected mice].
Wan SJ; Yang F; Huang XZ
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2007 Sep; 21(3):238-40. PubMed ID: 17971932
[TBL] [Abstract][Full Text] [Related]
16. Study on the inhibitory effect of antisense phosphorothioate oligodeoxynucleotide on coxsackie virus B replication in vitro.
Qi X; Li X; Liu M
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2000 Sep; 14(3):253-6. PubMed ID: 11498691
[TBL] [Abstract][Full Text] [Related]
17. Enhanced potency and efficacy of 29-mer shRNAs in inhibition of Enterovirus 71.
Tan EL; Tan TM; Chow VT; Poh CL
Antiviral Res; 2007 Apr; 74(1):9-15. PubMed ID: 17316836
[TBL] [Abstract][Full Text] [Related]
18. A small interfering RNA targeting coxsackievirus B3 protects permissive HeLa cells from viral challenge.
Ahn J; Jun ES; Lee HS; Yoon SY; Kim D; Joo CH; Kim YK; Lee H
J Virol; 2005 Jul; 79(13):8620-4. PubMed ID: 15956603
[TBL] [Abstract][Full Text] [Related]
19. Combination of RNA interference and virus receptor trap exerts additive antiviral activity in coxsackievirus B3-induced myocarditis in mice.
Stein EA; Pinkert S; Becher PM; Geisler A; Zeichhardt H; Klopfleisch R; Poller W; Tschöpe C; Lassner D; Fechner H; Kurreck J
J Infect Dis; 2015 Feb; 211(4):613-22. PubMed ID: 25193982
[TBL] [Abstract][Full Text] [Related]
20. Zinc finger antiviral protein inhibits coxsackievirus B3 virus replication and protects against viral myocarditis.
Li M; Yan K; Wei L; Yang J; Lu C; Xiong F; Zheng C; Xu W
Antiviral Res; 2015 Nov; 123():50-61. PubMed ID: 26343012
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
